GPNMB: emerging therapeutic target in cancer
Abstract: Molecularly targeted therapies are rapidly growing with respect to their clinical development and impact on cancer treatment due to their highly selective anti-tumor action. However, many aggressive cancers such as triple-negative breast cancer (TNBC) currently lack well-defined therapeutic targets against which such agents can be developed.
Read this review and sign up to receive OncoTargets and Therapy journal here: http://www.dovepress.com/articles.php?article_id=13605
3 Pins84 Followers